Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction

Journal of Investigational Allergology and Clinical Immunology

Volumn 18, Issue 4, 2008, Pages 272-278

  Zietkowski, Z ^a   Skiepko, R ^a   Tomasiak, M M ^a   Bodzenta Lukaszyk, A ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Airway inflammation; Asthma; Exercise induced bronchoconstriction; sCD40 ligand; sP selectin

Indexed keywords

CD40 LIGAND; EOSINOPHIL CATIONIC PROTEIN; NITRIC OXIDE; PADGEM PROTEIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; BLOOD LEVEL; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXERCISE INDUCED ASTHMA; EXERCISE TEST; FEMALE; HUMAN; INFLAMMATION; INHALATION TEST; MALE; SPIROMETRY; STATISTICAL SIGNIFICANCE;

ADULT; ANTIGENS, CD40; ASTHMA; ASTHMA, EXERCISE-INDUCED; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CD40 LIGAND; EXERCISE; FEMALE; HUMANS; MALE; P-SELECTIN; SPIROMETRY;

EID: 47749087039     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Greval IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111-35.
2. Wiley JA, Greha R, Harmsen AG. Exogenous CD40 ligand induces a pulmonary inflammation response. J Immunol.1997;158:2932-36.
3. Lei XF, Ohkawara Y, Stampfli MR, Mastuzzo C, Marr RA, Snider D, Xing Z, Jordana M. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin Invest. 1998;101:1342-47.
4. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is... J Allergy Clin Immunol. 2000;106:453-59.
5. Chhabra SK, Ojha UC. Late asthmatic response in exercise-induced asthma. Ann Allergy Asthma Immunol.1998;80:323-27.
6. Peroni DG, Boner AL. Exercise-induced asthma: is there space for late-phase reactions? Eur Respir J.1996;9:1335-38.
7. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R. The role of endothelium-derived mediators in exercise-induced bronchoconstriction. Int Arch Allergy Immunol. 2007;143(4):299-310.
8. Global Initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO Report 2005, publication 02-3659, www.ginasthma.org.
9. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202-18.
10. Ryan G, Dolovich MB, Roberts RS, Frith PA, Juniper EF, Hargreave FE, Newhouse MT. Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis. 1981;123:195-99.
11. Eggleston PA. Methods of exercise challenge. J Allergy Clin Immunol. 1984;73:666-69.
12. American Thoracic Society/American Lung Association Recommendations for On-line Measurement of Exhaled Nitric Oxide in Adults and the Recommendations for On-line, Offline and Nasal Expired Nitric Oxide Measurements in Children. Am J Respir Crit Care Med. 1999;160:2104-17.
13. Noelle RJ. CD40 and its ligand in cell-mediated immunity. Agents Actions Suppl. 1998;49:17-22.
14. Grewal IS, Flavell RA. The CD40 ligand. At the center of the immune universe? Immunol Res. 1997;16(1):59-70.
15. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci. 2001;58(1):4-43.
16. Graf D, Muller S, Korthauer U, van Kooten C, Weise C, Kroczek RA. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol. 1995;25(6):1749-54.
17. Propst SM, Denson R, Rothstein E, Estell K, Schwiebert LM. Proinflammatory and Th2-derived cytokines modulate CD-40 - mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. J Immunol. 2000;165:2214-21.
18. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci. USA 1997;94(5):1931-36.
19. Kowal K, Pampuch A, Kowal-Bielecka O, Du Buske LM, Bodzenta-Lukaszyk A. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus. Clin Exp Allergy. 2006;36:426-32.
20. Kowal K, Pampuch A, Kowal-Bielecka O, Iacoviello L, Bodzenta-Lukaszyk A. Soluble CD40 ligand in asthma patients during allergen challenge. J Thromb Haemost. 2006; 4: 2718-38.
21. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J. 2001;22:1561-71.
22. Danese S, Katz JA, Saibeni S, Papa A, Gasbarini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut. 2003;52:1435-41.
23. Virant FS. Exercise-induced bronchospasm: epidemiology, pathophysiology, and therapy. Med Sci Sports Exerc. 1992;8:851-55.
24. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR, Aitken ML. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2005;172:679-86.
25. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson D, Taylor DR. Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004;169:473-78.